BioDtech

Birmingham, United States Founded: 2003 • Age: 23 yrs Acquired By Predictive Oncology
Endotoxin detection, neutralization, and removal technologies are developed.
Request Access

About BioDtech

BioDtech is a company based in Birmingham (United States) founded in 2003 was acquired by Predictive Oncology in July 2020.. BioDtech has raised $1.6 million across 3 funding rounds from investors including Predictive Oncology, HHS and Greer Capital Advisors. BioDtech operates in a competitive market with competitors including Abcam, Sino Biological, GenScript, Stem Cell Technologies and Miltenyi Biotec, among others.

  • Headquarter Birmingham, United States
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $1.6 M (USD)

    in 3 rounds

  • Latest Funding Round
    $1.13 M (USD), Grant

    Sep 01, 2014

  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Predictive Oncology

    (Jul 06, 2020)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of BioDtech

BioDtech has successfully raised a total of $1.6M across 3 strategic funding rounds. The most recent funding activity was a Grant round of $1.13 million completed in September 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 3
  • Last Round Grant — $1.1M
  • First Round

    (01 Jul 2007)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Sep, 2014 Amount Grant - BioDtech Valuation

investors

HHS
Aug, 2010 Amount Seed - BioDtech Valuation Greer Capital Advisors
Jul, 2007 Amount Seed - BioDtech Valuation Greer Capital Advisors
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in BioDtech

BioDtech has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Predictive Oncology, HHS and Greer Capital Advisors. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
-
Founded Year Domain Location
Public health and human services are overseen by HHS.
Founded Year Domain Location
AI-based platform for cancer diagnostics and precision medicine is utilized.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by BioDtech

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - BioDtech

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Biodtech Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of BioDtech

BioDtech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Sino Biological, GenScript, Stem Cell Technologies and Miltenyi Biotec, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Biological reagents and antibodies are developed for life science research.
domain founded_year HQ Location
Reagents and kits are provided for clinical research applications.
domain founded_year HQ Location
Reagents and instruments are provided for life sciences research.
domain founded_year HQ Location
Developer of cell culture media and ancillary reagents for life science research
domain founded_year HQ Location
Develops tools and products for research and clinical application
domain founded_year HQ Location
Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Biodtech

Frequently Asked Questions about BioDtech

When was BioDtech founded?

BioDtech was founded in 2003 and raised its 1st funding round 4 years after it was founded.

Where is BioDtech located?

BioDtech is headquartered in Birmingham, United States. It is registered at Birmingham, Alabama, United States.

Is BioDtech a funded company?

BioDtech is a funded company, having raised a total of $1.6M across 3 funding rounds to date. The company's 1st funding round was a Seed of $1M, raised on Jul 01, 2007.

What does BioDtech do?

BioDtech was founded in 2003 and is based in Birmingham, United States. Products for the bioresearch and bioprocess sectors are developed, focusing on endotoxin detection, neutralization, and removal. Reagents for assay development are provided, along with services for endotoxin detection and removal from aqueous solutions using EndoBind-R technology. A license agreement with the National University of Singapore grants worldwide rights for these products.

Who are the top competitors of BioDtech?

BioDtech's top competitors include Abcam, Sino Biological and Meridian Bioscience.

Who are BioDtech's investors?

BioDtech has 3 investors. Key investors include Predictive Oncology, HHS, and Greer Capital Advisors.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available